These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7090334)

  • 21. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
    Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
    J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Change of complement system predicts the outcome of patients with severe thermal injury.
    Kang HJ; Kim JH; Lee EH; Lee YK; Hur M; Lee KM
    J Burn Care Rehabil; 2003; 24(3):148-53. PubMed ID: 12792234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced complement-mediated immune complex solubilization in leprosy patients.
    Ramanathan VD; Sharma P; Ramu G; Sengupta U
    Clin Exp Immunol; 1985 Jun; 60(3):553-8. PubMed ID: 3874729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the alternative pathway of human complement by haemoglobin.
    Wilson WA; Thomas EJ
    Clin Exp Immunol; 1979 Apr; 36(1):140-4. PubMed ID: 111881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the alternative pathway of the complement system by radiographic contrast media.
    Arroyave CM; Bhat KN; Crown R
    J Immunol; 1976 Nov; 117(5 Pt.2):1866-9. PubMed ID: 993582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating immune complexes in Indian childhood cirrhosis.
    Kalra V; Harkiss GD; Lachmann PJ; Ghai OP
    Clin Exp Immunol; 1982 Oct; 50(1):1-6. PubMed ID: 6924609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.
    Lew PD; Zubler R; Vaudaux P; Farquet JJ; Waldvogel FA; Lambert PH
    J Clin Invest; 1979 Feb; 63(2):326-34. PubMed ID: 429556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of complement activation by counterimmunoelectrophoresis (CIE).
    Arroyave CM; Tan EM
    J Immunol Methods; 1976; 13(2):101-12. PubMed ID: 824368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune complexes in retinitis pigmentosa.
    Heredia CD; Huguet J; Cols N; Engel P; García-Calderón PA
    Br J Ophthalmol; 1984 Nov; 68(11):811-4. PubMed ID: 6333894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephritic factor, C3 splitting activity, C3 and factor B breakdown products in glomerular diseases.
    De Vecchi A; Montagnino G; Scalia P; Tarantino A
    Ric Clin Lab; 1980; 10(1):93-7. PubMed ID: 6781054
    [No Abstract]   [Full Text] [Related]  

  • 33. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
    Tanaka C; Suhara Y; Kikkawa Y
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breakdown products of C3 and factor B in hemolytic-uremic syndrome.
    Kim Y; Miller K; Michael AF
    J Lab Clin Med; 1977 Apr; 89(4):845-50. PubMed ID: 845484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The opsonic activity of stored blood.
    McClellan MA; Alexander JW
    Transfusion; 1977; 17(3):227-32. PubMed ID: 405758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initiation of C3 cleavage in the alternative complement pathway.
    Fearon DT; Austen KF
    J Immunol; 1975 Nov; 115(5):1357-61. PubMed ID: 809512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of complement in porphyrin-induced photosensitivity.
    Lim HW; Gigli I
    J Invest Dermatol; 1981 Jan; 76(1):4-9. PubMed ID: 7462666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alkaline CPD and the preservation of RBC 2,3-DPG.
    Hess JR; Hill HR; Oliver CK; Lippert LE; Greenwalt TJ
    Transfusion; 2002 Jun; 42(6):747-52. PubMed ID: 12147028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dextrose-mediated aggregation of therapeutic monoclonal antibodies in human plasma: Implication of isoelectric precipitation of complement proteins.
    Luo S; Zhang B
    MAbs; 2015; 7(6):1094-103. PubMed ID: 26338058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating immune complexes in ulcerative colitis.--II. Correlation with serum protein concentrations and complement conversion products.
    Nielsen H; Petersen PH; Svehag SE
    Clin Exp Immunol; 1978 Jan; 31(1):81-91. PubMed ID: 639352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.